These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3486168)

  • 1. Treatment of cutaneous T cell lymphomas with PUVA.
    Rabbiosi G; Carcaterra A; Bellosta M
    Int J Tissue React; 1986; 8(2):141-3. PubMed ID: 3486168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Total skin electron beam irradiation in cutaneous T-cell lymphoma].
    Rübe C; Busch M; Willich N; Hess F; Schönekäs K; Kaudewitz P; Wendt T; Feist H; Dühmke E
    Strahlenther Onkol; 1996 Feb; 172(2):74-80. PubMed ID: 8669048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemotherapy for cutaneous T cell lymphoma. A follow-up study.
    Hönigsmann H; Brenner W; Rauschmeier W; Konrad K; Wolff K
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):238-45. PubMed ID: 6609177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches in cutaneous lymphoma.
    Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
    Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
    Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
    J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
    Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
    J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
    Tsimberidou AM; Giles FJ; Duvic M; Kurzrock R
    J Am Acad Dermatol; 2004 Aug; 51(2):200-4. PubMed ID: 15280837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
    Olsen EA; Kim YH; Kuzel TM; Pacheco TR; Foss FM; Parker S; Frankel SR; Chen C; Ricker JL; Arduino JM; Duvic M
    J Clin Oncol; 2007 Jul; 25(21):3109-15. PubMed ID: 17577020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series.
    Singh F; Lebwohl MG
    J Am Acad Dermatol; 2004 Oct; 51(4):570-3. PubMed ID: 15389192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
    Duvic M; Martin AG; Kim Y; Olsen E; Wood GS; Crowley CA; Yocum RC;
    Arch Dermatol; 2001 May; 137(5):581-93. PubMed ID: 11346336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is PUVA maintenance therapy necessary in patients with early-stage mycosis fungoides? Evaluation of a treatment guideline over a 28-month follow-up.
    Sánchez MA; González T; Gaitán MF; Zuluaga A; Jiménez SB; de Galvis YT
    Int J Dermatol; 2011 Sep; 50(9):1086-93. PubMed ID: 21375528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early stages of mycosis fungoides with narrowband ultraviolet B. A clinical, histological and molecular evaluation of results.
    Dereure O; Picot E; Comte C; Bessis D; Guillot B
    Dermatology; 2009; 218(1):1-6. PubMed ID: 18832806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant lymphoma of the skin].
    Nakajima H; Miyamoto H
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.